Moxiforce-CV 375 Tablet
Manufacturer
Mankind Pharma Ltd
Salt Composition
Amoxycillin (250mg) + Clavulanic Acid (125mg)
Key Information
Short Description
Moxiforce-CV 375 Tablet is an antibiotic that helps your body fight infections caused by bacteria. It is used to treat infections of the lungs, ear, nasal sinus, urinary tract, skin, and soft tissue.
Dosage Form
Tablet
Introduction
Moxiforce-CV 375 Tablet is an antibiotic that helps your body fight infections caused by bacteria. It is used to treat infections of the lungs (e.g., pneumonia), ear, nasal sinus, urinary tract, skin, and soft tissue. It will not work for viral infections such as the common cold.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Moxiforce-CV 375 Tablet is to be taken with food.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
Consuming alcohol with Moxiforce-CV 375 Tablet does not cause any harmful side effects.
Breastfeeding Warning
Moxiforce-CV 375 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnancy Warning
Moxiforce-CV 375 Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
How it works
Moxiforce-CV 375 Tablet is a combination of two medicines: Amoxycillin and Clavulanic Acid. Amoxycillin is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Amoxycillin against bacteria.
Quick Tips
Diarrhea may occur as a side effect. Taking probiotics along with Moxiforce-CV 375 Tablet may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps. Do not take antacids 2 hours before or after taking Moxiforce-CV 375 Tablet. Stop taking Moxiforce-CV 375 Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it. Do not use leftover medicine for treating any infection in the future. Always consult your doctor before taking any antibiotic. Stick to simple meals, avoid rich or spicy food and drink plenty of water while taking Moxiforce-CV 375 Tablet.
Related Medicines
Amoxyclav 375 Tablet
Augmentin 375 Tablet
Moxikind-CV 375 Tablet
Clavam 375 Tablet
MQ-Clav 375 Tablet
Saimox-CV 250mg/125mg Tablet
Granmox CV 250mg/125mg Tablet
Amvulac 250mg/125mg Tablet
Oremox 375 Tablet
Moxireta 250mg/125mg Tablet
Frequently asked questions
What is Moxiforce-CV 375 Tablet?
Moxiforce-CV 375 Tablet contains two active ingredients: Amoxycillin and Clavulanic acid. It is used to treat bacterial infections like tonsillitis, sinusitis, otitis media, respiratory tract infections, urinary tract infections, boils, abscesses, cellulitis, wound infection, and oral cavity infections.
Is Moxiforce-CV 375 Tablet safe?
Moxiforce-CV 375 Tablet is generally considered safe when taken as directed by a doctor. However, some patients may experience common side effects such as diarrhea, nausea, vomiting, rash, allergic reactions, and other possible side effects. If you have any persistent problems during treatment, inform your doctor immediately.
Are there any specific precautions for using Moxiforce-CV 375 Tablet?
Moxiforce-CV 375 Tablet may not be suitable for patients with known allergies to penicillins or other ingredients in the medicine. It is also not recommended for individuals with liver disease. It is crucial to inform your doctor about any pre-existing allergies before starting treatment.
Does Moxiforce-CV 375 Tablet affect birth control?
Yes, the use of Moxiforce-CV 375 Tablet can interfere with the efficacy of some contraceptive methods. Please consult your doctor to discuss appropriate alternatives (e.g., condoms, diaphragms, spermicides) while taking this medication.
Can I take a higher dose than prescribed for Moxiforce-CV 375 Tablet?
No, exceeding the recommended dose of Moxiforce-CV 375 Tablet can increase risks associated with side effects. The medicine takes time to show its full effect and treat the infection. If your symptoms worsen, please consult your doctor for re-evaluation.
How should I store and dispose of Moxiforce-CV 375 Tablet?
Store this medicine in the original container or packaging, tightly closed. Follow the storage instructions on the label provided with the medication. Do not discard unused medication down the drain or into garbage. Make sure it is inaccessible to pets, children, and other individuals.
Can I stop taking Moxiforce-CV 375 Tablet early if my symptoms subside?
No, do not discontinue taking Moxiforce-CV 375 Tablet before completing the full course of treatment. Even if you feel better, there is a possibility your infection is not completely resolved yet. Continue with your prescribed medication to allow for complete treatment.
Can Moxiforce-CV 375 Tablet cause an allergic reaction?
Yes, Moxiforce-CV 375 Tablet can trigger allergic reactions. It is especially not suitable for individuals with known penicillins allergies. Seek immediate medical attention if you experience signs of an allergic reaction such as hives, difficulty breathing, swelling of the face, lips, tongue or throat.
Can Moxiforce-CV 375 Tablet cause diarrhea?
Yes, Moxiforce-CV 375 Tablet can lead to diarrhea. This is a common side effect associated with antibiotics. It may be caused by the destruction of beneficial bacteria in your gut and intestinal system.
Can I use Moxiforce-CV 375 Tablet for a cold or flu?
No, Moxiforce-CV 375 Tablet is not suitable for treating viral infections like the common cold or flu. Seek medical advice and avoid self-treatment.
Does Moxiforce-CV 375 Tablet cause drowsiness?
No, Moxiforce-CV 375 Tablet does not typically cause drowsiness. If you experience any such effects, consult your doctor.
